Abstract
Background: Critical hypoxia in this COVID-19 pandemic results in high mortality and economic loss worldwide. Initially, this disease’ pathophysiology was poorly understood and interpreted as a SARS (Severe Acute Respiratory Syndrome) pneumonia. The severe atypical lung CAT scan images alerted all countries, including the poorest, to purchase lacking sophisticated ventilators. However, up to 88% of the patients on ventilators lost their lives. It was suggested that COVID-19 could be similar to a High-Altitude Pulmonary Edema (HAPE). New observations and pathological findings are gradually clarifying the disease.
Methods: As high-altitude medicine and hypoxia physiology specialists working and living in the highlands for over 50 years, we perform a perspective analysis of hypoxic diseases treated at high altitudes and compare them to Covid-19. Oxygen transport physiology, SARS-Cov-2 characteristics, and its transmission, lung imaging in COVID-19, and HAPE, as well as the causes of clinical signs and symptoms, are discussed.
Results: High-altitude oxygen transport physiology has been systematically ignored. COVID-19 signs and symptoms indicate a progressive and irreversible failure in the oxygen transport system, secondary to pneumolysis produced by SARS-Cov-2’s alveolar-capillary membrane “attack”. HAPE’s pulmonary compromise is treatable and reversible. COVID-19 is associated with several diseases, with different individual outcomes, in different countries, and at different altitudes.
Conclusions: The pathophysiology of High-altitude illnesses can help explain COVID-19 pathophysiology, severity, and management. Early diagnosis and use of EPO, acetylsalicylic-acid, and other anti-inflammatories, oxygen therapy, antitussives, antibiotics, and the use of Earth open-circuit- astronaut-resembling suits to return to daily activities, should all be considered. Ventilator use can be counterproductive. Immunity development is the only feasible long-term survival tool.
Keywords: HAPE, tolerance to hypoxia, SARS-Cov-2, Polyerythrocythemia, EPO, coronavirus suit.
Graphical Abstract
[http://dx.doi.org/10.2174/1574887115999200228100745] [PMID: 32116200]
[http://dx.doi.org/10.1001/jama.2020.6775] [PMID: 32320003]
[http://dx.doi.org/10.2967/jnumed.120.246256] [PMID: 32238429]
[http://dx.doi.org/10.1007/s12020-020-02294-5] [PMID: 32279224]
[http://dx.doi.org/10.1016/j.envint.2020.105730] [PMID: 32294574]
[http://dx.doi.org/10.1093/infdis/jiaa274] [PMID: 32432672]
[http://dx.doi.org/10.1056/NEJMc2004973] [PMID: 32182409]
[http://dx.doi.org/10.1016/j.resp.2020.103443] [PMID: 32333993]
[http://dx.doi.org/10.1186/s40249-020-00646-x] [PMID: 32183901]
[http://dx.doi.org/10.1016/j.trsl.2020.04.007] [PMID: 32299776]
[http://dx.doi.org/10.1093/ajcp/aqaa062] [PMID: 32275742]
[http://dx.doi.org/10.1152/japplphysiol.01167.2004] [PMID: 15703168]
[http://dx.doi.org/10.15252/embj.20105114] [PMID: 32246845]
[http://dx.doi.org/10.1038/s41368-020-0074-x] [PMID: 32094336]
[http://dx.doi.org/10.1002/lary.28692]
[http://dx.doi.org/10.1152/ajpheart.00331.2008]
[http://dx.doi.org/10.1007/s00134-016-4611-1] [PMID: 28108768]
[http://dx.doi.org/10.1186/s13054-020-02880-z] [PMID: 32299472]
[http://dx.doi.org/10.7759/cureus.7343] [PMID: 32226695]
[http://dx.doi.org/10.1089/ham.2016.0100] [PMID: 28846035]
[http://dx.doi.org/10.1007/978-1-4615-4711-2_7] [PMID: 10634995]
[http://dx.doi.org/10.1148/radiol.2020200230] [PMID: 32017661]
[http://dx.doi.org/10.1056/NEJMoa2015432] [PMID: 32437596]
[http://dx.doi.org/10.1580/1080-6032(1996)007[0127:TOHAPE]2.3.CO;2] [PMID: 11990106]
[http://dx.doi.org/10.1378/chest.45.3.273] [PMID: 14132273]
[http://dx.doi.org/10.1016/j.wem.2018.12.009] [PMID: 30852106]
[http://dx.doi.org/10.1007/s00392-020-01626-9] [PMID: 32161990]
[http://dx.doi.org/10.1007/s00395-020-0791-5] [PMID: 32274570]
[PMID: 17072074]
[http://dx.doi.org/10.1016/j.jacc.2020.04.031] [PMID: 32311448]
[http://dx.doi.org/10.34172/aim.2020.09] [PMID: 32271601]
[http://dx.doi.org/10.1155/2013/241569] [PMID: 23690739]
[PMID: 16204801]
[PMID: 18204195]
[PMID: 16204789]
[http://dx.doi.org/10.1007/s12291-010-0088-9] [PMID: 22211016]
[http://dx.doi.org/10.1016/j.ajem.2020.04.048] [PMID: 32317203]
[http://dx.doi.org/10.1002/jmv.25839] [PMID: 32270515]
[http://dx.doi.org/10.1113/jphysiol.2005.093328] [PMID: 16051624]
[http://dx.doi.org/10.1016/j.resp.2020.103476] [PMID: 32522574]
[http://dx.doi.org/10.1186/s10020-020-00186-y] [PMID: 32546125]
[http://dx.doi.org/10.1182/blood-2004-02-0744] [PMID: 15205261]
[http://dx.doi.org/10.1016/j.ydbio.2004.08.025] [PMID: 15531367]
[http://dx.doi.org/10.1007/s12291-020-00935-0]